After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
ALNY belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Alnylam Pharmaceuticals Inc is $35.25B. A total of 0.55 million shares were traded on the day, compared to an average of 991.03K shares.
In the most recent transaction, Greenstreet Yvonne sold 15,000 shares of ALNY for 280.00 per share on Aug 20 ’24. After the transaction, the Chief Executive Officer now owns 73,441 company shares. In a previous transaction on Aug 20 ’24, Greenstreet Yvonne bought 15,000 shares at 280.00 per share.
Among the insiders who sold shares, Fitzgerald Kevin Joseph disposed of 22,025 shares on Aug 12 ’24 at a per-share price of $270.99. This resulted in the CSO & EVP, Head of Research holding 12,881 shares of ALNY after the transaction. In another insider transaction, Fitzgerald Kevin Joseph bought 22,025 shares at $269.52 per share on Aug 12 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ALNY has a high of $287.55 and a low of $141.98.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ALNY’s latest balance sheet shows that the firm has $2.44B in Cash & Short Term Investments as of fiscal 2021. There were $997.59M in debt and $695.71M in liabilities at the time. Its Book Value Per Share was -$0.02, while its Total Shareholder’s Equity was $588.20M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALNY is Buy with a score of 4.30.
